Cortical Astrocytes Acutely Exposed to the Monomethylarsonous Acid (MMAIII) Show Increased Pro-inflammatory Cytokines Gene Expression that is Consistent with APP and BACE-1: Over-expression
Article
Overview
Research
Identity
Additional Document Info
View All
Overview
abstract
Long-term exposure to inorganic arsenic (iAs) through drinking water has been associated with cognitive impairment in children and adults; however, the related pathogenic mechanisms have not been completely described. Increased or chronic inflammation in the brain is linked to impaired cognition and neurodegeneration; iAs induces strong inflammatory responses in several cells, but this effect has been poorly evaluated in central nervous system (CNS) cells. Because astrocytes are the most abundant cells in the CNS and play a critical role in brain homeostasis, including regulation of the inflammatory response, any functional impairment in them can be deleterious for the brain. We propose that iAs could induce cognitive impairment through inflammatory response activation in astrocytes. In the present work, rat cortical astrocytes were acutely exposed in vitro to the monomethylated metabolite of iAs (MMAIII), which accumulates in glial cells without compromising cell viability. MMAIII LD50 in astrocytes was 10.52 μM, however, exposure to sub-toxic MMAIII concentrations (50–1000 nM) significantly increased IL-1β, IL-6, TNF-α, COX-2, and MIF-1 gene expression. These effects were consistent with amyloid precursor protein (APP) and β-secretase (BACE-1) increased gene expression, mainly for those MMAIII concentrations that also induced TNF-α over-expression. Other effects of MMAIII on cortical astrocytes included increased proliferative and metabolic activity. All tested MMAIII concentrations led to an inhibition of intracellular lactate dehydrogenase (LDH) activity. Results suggest that MMAIII induces important metabolic and functional changes in astrocytes that may affect brain homeostasis and that inflammation may play a major role in cognitive impairment-related pathogenicity in As-exposed populations. © 2016, Springer Science Business Media New York.
Long-term exposure to inorganic arsenic (iAs) through drinking water has been associated with cognitive impairment in children and adults; however, the related pathogenic mechanisms have not been completely described. Increased or chronic inflammation in the brain is linked to impaired cognition and neurodegeneration; iAs induces strong inflammatory responses in several cells, but this effect has been poorly evaluated in central nervous system (CNS) cells. Because astrocytes are the most abundant cells in the CNS and play a critical role in brain homeostasis, including regulation of the inflammatory response, any functional impairment in them can be deleterious for the brain. We propose that iAs could induce cognitive impairment through inflammatory response activation in astrocytes. In the present work, rat cortical astrocytes were acutely exposed in vitro to the monomethylated metabolite of iAs (MMAIII), which accumulates in glial cells without compromising cell viability. MMAIII LD50 in astrocytes was 10.52 μM, however, exposure to sub-toxic MMAIII concentrations (50–1000 nM) significantly increased IL-1β, IL-6, TNF-α, COX-2, and MIF-1 gene expression. These effects were consistent with amyloid precursor protein (APP) and β-secretase (BACE-1) increased gene expression, mainly for those MMAIII concentrations that also induced TNF-α over-expression. Other effects of MMAIII on cortical astrocytes included increased proliferative and metabolic activity. All tested MMAIII concentrations led to an inhibition of intracellular lactate dehydrogenase (LDH) activity. Results suggest that MMAIII induces important metabolic and functional changes in astrocytes that may affect brain homeostasis and that inflammation may play a major role in cognitive impairment-related pathogenicity in As-exposed populations. © 2016, Springer Science%2bBusiness Media New York.
publication date
funding provided via
published in
Research
keywords
APP; Arsenic; Astrocytes; BACE-1; Cognitive; Inflammation amyloid precursor protein; arsenic acid derivative; beta secretase 1; cyclooxygenase 2; interleukin 1beta; interleukin 6; lactate dehydrogenase; macrophage migration inhibition factor; monomethylarsonous acid; tumor necrosis factor; unclassified drug; amyloid precursor protein; aspartic proteinase; Bace protein, rat; cytokine; monomethylarsonous acid; organometallic compound; secretase; acute toxicity; animal cell; animal tissue; Article; astrocyte; brain cortex; cell proliferation; cell viability; cognitive defect; concentration (parameters); controlled study; cytotoxicity; enzyme activity; gene overexpression; genetic association; glia cell; immunohistochemistry; methylation; nervous system inflammation; newborn; nonhuman; oxidative phosphorylation; oxidative stress; priority journal; rat; animal; astrocyte; cell culture; cell line; cell survival; drug effects; gene expression regulation; genetics; homeostasis; metabolism; Wistar rat; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Astrocytes; Cell Line; Cell Survival; Cells, Cultured; Cytokines; Gene Expression Regulation; Homeostasis; Organometallic Compounds; Rats, Wistar
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue